Triviño Ibáñez, Eva María
45  Ergebnisse:
Personensuche X
?
 
?
7

Dihydrocapsiate does not increase energy expenditure nor fa..:

Osuna Prieto, Francisco Javier ; Acosta, Francisco M ; Pérez de Arrilucea Le Floc'h, Unai A...
Francisco J. Osuna-Prieto. [et al.] (2022) Dihydrocapsiate does not increase energy expenditure nor fat oxidation during aerobic exercise in men with overweight/obesity: a randomized, tripleblinded, placebo-controlled, crossover trial, Journal of the International Society of Sports Nutrition, 19:1, 417-436, DOI: [10.1080/15502783.2022.2099757].  , 2022
 
?
9

[18F]FDG PET/CT in Short-Term Complications of COVID-19: Me..:

Triviño Ibáñez, Eva María ; Jiménez Rodríguez, Beatriz María ; Rudolphi Solero, Teodoro...
Triviño-Ibáñez, E.M. [et al.]. [18F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function. Diagnostics 2022, 12, 835. [https://doi.org/10.3390/diagnostics12040835].  , 2022
 
?
10

Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors ..:

Jiménez Rodríguez, Beatriz María ; Triviño Ibáñez, Eva María ; Gutiérrez Fernández, José...
Jiménez-Rodríguez, B.M. [et al.]. Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study. Healthcare 2022, 10, 2341. [https://doi.org/10.3390/healthcare10122341].  , 2022
 
?
14

Impact of amyloid-PET in daily clinical management of patie..:

Triviño Ibáñez, Eva María ; Sánchez-Vañó, Raquel ; Sopena Novales, Pablo...
Triviño-Ibáñez, E. M., Sánchez-Vañó, R., Sopena-Novales, P., Romero-Fábrega, J. C., Rodríguez-Fernández, A., Pardo, C. C., . & Gómez-Río, M. (2019). Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria. Medicine, 98(29)..  , 2019
 
?
15

Utilidad de la 18F-FDG PET/TC precoz en el manejo terapéuti..:

Triviño Ibáñez, Eva María
Triviño Ibáñez, E.M. Utilidad de la 18F-FDG PET/TC precoz en el manejo terapéutico y estratificación dinámica del riesgo de pacientes con carcinoma diferenciado de tiroides de riesgo alto/intermedio. Granada: Universidad de Granada, 2016. [http://hdl.handle.net/10481/43031].  , 2016
 
1-15